These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 29080702)
21. CN-3 increases TMZ sensitivity and induces ROS-dependent apoptosis and autophagy in TMZ-resistance glioblastoma. Xue YY; Lu YY; Sun GQ; Fang F; Ji YQ; Tang HF; Qiu PC; Cheng G J Biochem Mol Toxicol; 2022 Mar; 36(3):e22973. PubMed ID: 34967073 [TBL] [Abstract][Full Text] [Related]
22. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis. Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235 [TBL] [Abstract][Full Text] [Related]
23. Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells. Silva VAO; Rosa MN; Miranda-Gonçalves V; Costa AM; Tansini A; Evangelista AF; Martinho O; Carloni AC; Jones C; Lima JP; Pianowski LF; Reis RM Invest New Drugs; 2019 Apr; 37(2):223-237. PubMed ID: 29931585 [TBL] [Abstract][Full Text] [Related]
24. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide. Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046 [TBL] [Abstract][Full Text] [Related]
25. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response. Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660 [TBL] [Abstract][Full Text] [Related]
26. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
27. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity. Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739 [TBL] [Abstract][Full Text] [Related]
29. Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling. Ho KH; Lee YT; Chen PH; Shih CM; Cheng CH; Chen KC Neurotherapeutics; 2021 Apr; 18(2):1371-1392. PubMed ID: 33410111 [TBL] [Abstract][Full Text] [Related]
30. Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside. Fleurence J; Bahri M; Fougeray S; Faraj S; Vermeulen S; Pinault E; Geraldo F; Oliver L; Véziers J; Marquet P; Rabé M; Gratas C; Vallette F; Pecqueur C; Paris F; Birklé S Int J Cancer; 2020 Jan; 146(2):424-438. PubMed ID: 31241171 [TBL] [Abstract][Full Text] [Related]
31. Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy. Hwang TW; Kim DH; Kim DB; Jang TW; Kim GH; Moon M; Yoon KA; Choi DE; Park JH; Kim JJ Int J Mol Med; 2019 Mar; 43(3):1478-1486. PubMed ID: 30664150 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma. Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. Shi L; Zhang S; Feng K; Wu F; Wan Y; Wang Z; Zhang J; Wang Y; Yan W; Fu Z; You Y Int J Oncol; 2012 Jan; 40(1):119-29. PubMed ID: 21879257 [TBL] [Abstract][Full Text] [Related]
34. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells. Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061 [TBL] [Abstract][Full Text] [Related]
35. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539 [TBL] [Abstract][Full Text] [Related]
36. Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma. Sun Q; Pei C; Li Q; Dong T; Dong Y; Xing W; Zhou P; Gong Y; Zhen Z; Gao Y; Xiao Y; Su J; Ren H Biochem Biophys Res Commun; 2018 Feb; 496(4):1040-1046. PubMed ID: 29366782 [TBL] [Abstract][Full Text] [Related]
37. BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide. Chen CM; Syu JP; Way TD; Huang LJ; Kuo SC; Lin CT; Lin CL Int J Mol Med; 2015 Nov; 36(5):1244-52. PubMed ID: 26329365 [TBL] [Abstract][Full Text] [Related]
38. MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway. Huang BS; Luo QZ; Han Y; Huang D; Tang QP; Wu LX J Cell Biochem; 2017 Oct; 118(10):3452-3461. PubMed ID: 28332226 [TBL] [Abstract][Full Text] [Related]
39. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
40. Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma. Xipell E; Gonzalez-Huarriz M; Martinez de Irujo JJ; García-Garzón A; Lang FF; Jiang H; Fueyo J; Gomez-Manzano C; Alonso MM Oncotarget; 2016 May; 7(21):30626-41. PubMed ID: 27121320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]